期刊文献+

人乳腺癌细胞化疗敏感性与相关基因表达的关系

Chemotherapy sensitivity and associated gene expression in human breast cancer cells
下载PDF
导出
摘要 目的探讨人乳腺癌细胞化疗敏感性与多药耐药相关基因和凋亡调控基因表达的关系。方法MTT法检测5株人乳腺癌细胞株Bcap37、MCF-7、T47D、MDA-MB-231和MDA-MB-435对阿霉素(ADM)、顺铂(DDP)、丝裂霉素(MMC)、5-氟尿嘧啶(5-Fu)、卡氮芥(BCNU)的敏感性。流式细胞术检测多药耐药基因P-糖蛋白(P-GP)、谷胱甘肽-S-转移酶-π(GST-π)、肺耐药蛋白(LRP)、多药耐药相关蛋白(MRP)和甲基鸟嘌呤甲基转移酶(MGMT)等耐药相关基因和凋亡调控基因FAS、BCL-2、P53和P16的表达。结果不同人乳腺癌细胞株对同一药物敏感性差异较大。相关分析表明,细胞株对5-Fu的敏感性与P16表达呈正相关(P<0.01),对其余药物的敏感性与所检基因的表达水平无关。结论人乳腺癌细胞株对5-Fu的敏感性与P16表达有关。 Objective To explore the relationship of chemotherapy sensitivity and expression of multidrug resistance genes and apoptosis regulation genes in human breast cancer cell lines. Methods MTT assay was used to detect the sensitivity to adriamycin ( ADM ), cisplatinum ( DDP), mitomycin C ( MMC ), fluorouracilum ( 5-Fu), carmustine (BCNU) in five breast cancer cell lines including Bcap37, MCF-7, T47D, MDA-MB-231 and MDA-MB-435. Multidrug resistance genes including P-glycoprotein (P-GP), Glutsthione-s-transferases-Л (GST-Л), Lung resistance protein (LRP), multidrug resistance related protein (MRP) , MGMT and apoptosis regulation genes FAS , BCL-2, P53 and P16 were examined by flow cytometry(FCM). Results The chemotherapy sensitivity was obviously divergent in different breast cancer cell lines. The correlation analysis showed that there were positive correlations between the sensitivity to 5-Fu in breast cancer cell lines and the expression of P16. There was no correlation among the sensitivity to other drugs and expression of other genes. Conclusions The sensitivity to 5-Fu is related to the expression of P16 in breast cancer cell lines.
出处 《基础医学与临床》 CSCD 北大核心 2006年第8期851-855,共5页 Basic and Clinical Medicine
关键词 乳腺癌细胞株 流式细胞术 化疗敏感性 多药耐药相关基因 凋亡调控基因 breast cancer cell line flow cytometry chemotherapy sensitivity multidrug resistance genes apoptosis regulation genes
  • 相关文献

参考文献2

二级参考文献29

  • 1Okuda K. Hepatocellular cal;cinoma. J Hepatol 2000; 32:225-37.
  • 2Lai CL, Gregory PB, Wu PC, Lok AS, Wong KP, Ng MM.Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance. Cancer 1987; 60:1107-10.
  • 3Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE.Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989; 49: 2506-9.
  • 4Paquet KJ, Kalk JF, Cuan-Orozco F, Siemens F, Koussouris P, Mercado MA. Hepatic chemoinfusion of 5-FU in metastasis of gastrointestinal cancer and advanced primary hepatocellular carcinoma. Eur J Surg Oncol 1992; 18: 156-61.
  • 5Kajanti M, Pyrhonen S, Mantyla M, Rissanen P. Intraarterial and intravenous use of 4' epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison. Am J Clin Oncol 1992; 15: 37-40.
  • 6Ravikumar TS, Pizzorno G, Bodden W, Marsh J, Strair R,Pollack J, et al. Percutaneous hepatic vein isolation and highdose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol 1994; 12: 2723-36.
  • 7Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trails. Ann Oncol 1997; 8: 117-36.
  • 8Weiman A, Oldhafer KJ, Pichlmayr R. Primary liver cancer.Curr Opin Oncol 1995; 7: 387- 96.
  • 9Di Maio M, De Maio E, Perrone F, Pignata S, Daniele B.Hepatocellular carcinoma: systemic treatments. J Clin Gastroenterol 2002; 35: S109-14.
  • 10Blagosklonny MV. P53: an ubiquitous target of anticancer drugs. Int J Cancer 2002; 98: 161-6.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部